Liquid chromatography-tandem mass spectrometric assay for the light sensitive calcium channel antagonist lacidipine in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 66, Issue , 2012, Pages 211-217

  Karra, Vijaya Kumari ^a   Pilli, Nageswara Rao ^a   Polagani, Srinivasa Rao ^b   Inamadugu, Jaswanth Kumar ^c   Seshagiri Rao, J V L N ^d  

^a JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^b RAYALASEEMA UNIVERSITY   (India)

^c SRI VENKATESWARA UNIVERSITY   (India)

^d ANDHRA UNIVERSITY   (India)

Author keywords

Lacidipine in human plasma; Liquid chromatography tandem mass spectrometry; Method validation; Pharmacokinetic studies; Solid phase extraction (SPE)

Indexed keywords

ACETONITRILE; AMMONIUM ACETATE; CARBAMAZEPINE; LACIDIPINE;

ACCURACY; ARTICLE; BLOOD SAMPLING; CHEMICAL REACTION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; FLOW RATE; HUMAN; HUMAN EXPERIMENT; LIGHT; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

CALCIUM CHANNEL BLOCKERS; CALIBRATION; CHROMATOGRAPHY, LIQUID; DIHYDROPYRIDINES; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84861223440     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.02.022     Document Type: Article

References (17)

1. Lee C.R., Bryson H.M. Lacidipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension. Drugs 1994, 48:274-296.
2. McCormack P.L., Wagstaff A.J. Lacidipine: a review of its use in the management of hypertension. Drugs 2003, 63:2327-2356.
3. Tcherdakoff P., Mallion J.M., Rahn K.H. French large-scale study evaluating the tolerability and efficacy of lacidipine. J. Cardiovasc. Pharmacol. 1995, 25:S27-S32.
4. Anacak G.Y., Ustünes L., Dilsiz O.Y., Ergul A. Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure. Vascul. Pharmacol. 2010, 53:193-199.
5. Toniolo R., Narda F.D., Bontempelli G., Ursini F. An electroanalytical investigation on the redox properties of lacidipine supporting its anti-oxidant effect. Bioelectrochemistry 2000, 51:193-200.
6. Leonetti G. Comparative study of lacidipine and nicidipine SR in the treatment of hypertension: an Italian multicenter study. J. Cardiovasc. Pharmacol. 1991, 17:S31-S34.
7. Dino M., Emiliangelo R., Toson G., Giovanni G. Pharmacology of lacidipine, a vascular-selective calcium antagonist. J. Cardiovasc. Pharmacol. 1991, 17:S1-S8.
8. Baranda A.B., Etxebarria N., Jimenez R.M., Alonso R.M. Development of a liquid-liquid extraction procedure for five 1,4-dihydropyridines calcium channel antagonists from human plasma using experimental design. Talanta 2005, 67:933-941.
9. Lopez J.A., Marti{dotless}nez V., Alonso R.M., Jimenez R.M. High-performance liquid chromatography with amperometric detection applied to the screening of 1,4-dihydropyridines in human plasma. J. Chromatogr. A 2000, 870:105-114.
10. Pellegatti M., Braggio S., Sartori S. Validation of a high-performance liquid chromatographic-radioimmunoassay method for the determination of lacidipine in plasma. J. Chromatogr. Biomed. Appl. 1992, 573:105-111.
11. Kharat V.R., Verma K.K., Dhake J.D. Determination of lacidipine from urine by HPTLC using off-line SPE. J. Pharm. Biomed. Anal. 2002, 28:789-793.
12. Rossato P., Scandola M., Grossi P. Investigation into lacidipine and related metabolites by high-performance liquid chromatography-mass spectrometry. J. Chromatogr. 1993, 647:155-166.
13. Ramakrishna N.V.S., Vishwottam K.N., Puran S., Manoj S., Santosh M., Koteshwara M. Simple, sensitive and rapid liquid chromatographic/electrospray ionization tandem mass spectrometric method for the quantification of lacidipine in human plasma. J. Mass Spectrom. 2004, 39:824-832.
14. Tang J., Zhu R., Zhao R., Cheng G., Peng W. Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of lacidipine in human plasma and its application in a pharmacokinetic study. J. Pharm. Biomed. Anal. 2008, 47:923-928.
15. De F.P., Bovina E., Da R.L., Fiori J., Cavrini V. Photodegradation studies on lacidipine in solution: basic experiments with a cis-trans reversible photoequilibrium under UV-A radiation exposure. J. Pharm. Biomed. Anal. 2002, 27:803-812.
16. Baranda A.B., Alonso R.M., Jimenez R.M., Weinmann W. Instability of calcium channel antagonists during sample preparation for LC-MS-MS analysis of serum samples. Forensic Sci. Int. 2006, 156:23-34.
17. Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, 2001.